Genedata and Sophion Bioscience Announce New Genedata Ready-to-Run Partnership
Share Article
Integration of Sophion QPatch II and Qube 384 instruments with Genedata Screener enterprise software streamlines molecular testing on ion channels in pharma R&D.
The combined power of Sophion Analyzer and Genedata Screener will enable advanced electrophysiological analysis and data analysis in a screening context. BASEL, Switzerland and BALLERUP, Denmark (PRWEB) June 09, 2021 Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced Sophion Bioscience, a global leader in automated patch clamp (APC) technology, as a new Genedata Ready-to-Run partner. Sophion joins a continually expanding group of leading technology providers who collaborate with Genedata to offer standardized integrations with the Genedata Biopharma Platform. The deep integration of Sophion QPatch II and Qu